Finance

Beta
Lists
NRIX:NASDAQ
Nurix Therapeutics Inc
24,26 USD
+1,72%
(+0,41) 1D
24,25 USD
-0,04% (-0,010)
After hours
Closed: 30-июн., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRIX...
Open
23,94 USD
High
24,88 USD
Low
23,50 USD
Mkt. cap
2,51 млд
Avg. vol.
2,99 млн
Volume
161,00
52-wk high
24,88 USD
52-wk low
8,20 USD
EPS
-3,16 USD
Beta
1,86
Shares outstanding
103,41 млн
No. of employees
317
Open
23,94 USD
High
24,88 USD
Low
23,50 USD
Mkt. cap
2,51 млд
Avg. vol.
2,99 млн
Volume
161,00
52-wk high
24,88 USD
52-wk low
8,20 USD
EPS
-3,16 USD
Beta
1,86
Shares outstanding
103,41 млн
No. of employees
317
News stories
From sources across the web
About Nurix Therapeutics Inc
CEO-
Employees317
Founded2009
HeadquartersБрисбен, Калифорния, Америка Кошмо Штаттары
Sector-
Websitenurixtx.com
Analyst ratings
Based on 12 analysts giving stock ratings to NRIX in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for NRIX in the last 3 months.
Highest
Current 24,26 USD
45,00 USD (+85,49%)
Average
33,00 USD (+36,03%)
Lowest
25,00 USD (+3,05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kostas Biliouris
Oppenheimer
Buy
Maintained
28,00 USD
+15,4%
06/29/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
34,00 USD
+40,1%
06/15/2026
Roger Song
Jefferies
Buy
Maintained
45,00 USD
+85,5%
06/15/2026
Gil Blum
Needham
Buy
Maintained
34,00 USD
+40,1%
06/15/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
06/11/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
32,00 USD
+31,9%
06/11/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
36,00 USD
+48,4%
06/08/2026
Jeet Mukherjee
BTIG
Buy
Maintained
32,00 USD
+31,9%
06/11/2026
Gregory Renza
Truist Financial
Buy
Reiterated
32,00 USD
+31,9%
06/09/2026
Derek Archila
Wells Fargo
Hold
Downgraded
25,00 USD
+3,1%
06/09/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
28,00 USD
+15,4%
05/13/2026
Biren Amin
Piper Sandler
Buy
Maintained
35,00 USD
+44,3%
05/13/2026
Brian Abrahams
RBC Capital
Buy
Reiterated
30,00 USD
+23,7%
04/08/2026
Nevin Varghese
RBC Capital
Buy
Reiterated
30,00 USD
+23,7%
04/08/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
30,00 USD
+23,7%
01/29/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. май
2025-ж. авг.
2025-ж. ноя.
2026-ж. фев.
Revenue
44,06 млн
7,89 млн
13,58 млн
6,25 млн
Cost of goods sold
78,10 млн
86,12 млн
83,02 млн
84,14 млн
Cost of revenue
78,10 млн
86,12 млн
83,02 млн
84,14 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,28 млн
13,16 млн
13,65 млн
14,61 млн
Operating expense
14,28 млн
13,16 млн
13,65 млн
14,61 млн
Total operating expenses
92,38 млн
99,28 млн
96,67 млн
98,75 млн
Operating income
-48,32 млн
-91,38 млн
-83,10 млн
-92,50 млн
Other non operating income
-
-
-
-
EBT including unusual items
-42,70 млн
-86,42 млн
-78,22 млн
-87,17 млн
EBT excluding unusual items
-42,70 млн
-86,42 млн
-78,22 млн
-87,17 млн
Income tax expense
760,00 миң
-
-
-
Effective tax rate
-1,78%
-
-
-
Other operating expenses
-
-
-
-
Net income
-43,46 млн
-86,42 млн
-78,22 млн
-87,17 млн
Net profit margin
-98,66%
-1 094,77%
-576,13%
-1 394,34%
Earnings per share
-0,52
-1,03
-0,82
-0,79
Interest and investment income
5,62 млн
4,96 млн
4,87 млн
5,32 млн
Interest expense
-
-
-
-
Net interest expenses
5,62 млн
4,96 млн
4,87 млн
5,32 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,08 млн
-89,36 млн
-81,58 млн
-90,30 млн
Gain or loss from assets sale
-
-
89,00 миң
160,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer